Medical SIBs, very interesting…
Repurposing Social Impact Bonds for Medicine
Bruce Bloom – SSIR
One mechanism that could fill this funding gap is the social impact bond (SIB)—the “pay for success” scheme structured to give funders a return on investment when the public interest initiative they support achieves positive results. In the case of generic drug repurposing research, the return on investment could come from some of the healthcare savings that the repurposed drug’s use would generate. In fact, it is likely that such healthcare savings would be greater than the amount needed to repay SIB investors, meaning that the amount of money saved by citizens and governments also would be significant. These financial benefits and improved health outcomes, in turn, could encourage governments, which usually do not fund generic drug repurposing trials, to support more such research.